^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

anti-LeY- scFv-CD28-ζ vector

i
Other names: anti-LeY- scFv-CD28-ζ vector, anti-Lewis-Y chimeric antigen receptor, anti-LeY- scFv-CD28- zeta vector, LeY CAR T
Associations
Trials
Company:
BMS, Peter MacCallum Cancer Centre
Drug class:
Lewis Y antigen-targeted CAR-T immunotherapy
Associations
Trials